AstraZeneca is a global, science-led biopharmaceutical company headquartered in Cambridge, United Kingdom. It discovers, develops, manufactures, and commercializes prescription medicines across key therapy areas including oncology; cardiovascular, renal and metabolism; respiratory and immunology; vaccines and immune therapies; and rare diseases (via Alexion).
From a manufacturing and process perspective, AstraZeneca’s operations cover small-molecule active pharmaceutical ingredients and finished dosage forms, as well as biologics such as monoclonal antibodies and other protein therapeutics. The company maintains a worldwide network for process development, scale-up, sterile fill–finish, and packaging, supported by extensive in-house research and external collaborations. Its activities connect advanced chemistry, bioprocess engineering, and quality-controlled GMP production to supply medicines globally.
